左室心肌做功对急性心肌梗死患者急诊PCI术后MACE发生的预测价值

徐芳, 徐俊杰, 吴春苑, 等. 左室心肌做功对急性心肌梗死患者急诊PCI术后MACE发生的预测价值[J]. 临床心血管病杂志, 2022, 38(12): 960-966. doi: 10.13201/j.issn.1001-1439.2022.12.007
引用本文: 徐芳, 徐俊杰, 吴春苑, 等. 左室心肌做功对急性心肌梗死患者急诊PCI术后MACE发生的预测价值[J]. 临床心血管病杂志, 2022, 38(12): 960-966. doi: 10.13201/j.issn.1001-1439.2022.12.007
XU Fang, XU Junjie, WU Chunyuan, et al. Predictive value of left ventricular global myocardial work on MACE occurrence after emergency PCI in patients with acute myocardial infarction[J]. J Clin Cardiol, 2022, 38(12): 960-966. doi: 10.13201/j.issn.1001-1439.2022.12.007
Citation: XU Fang, XU Junjie, WU Chunyuan, et al. Predictive value of left ventricular global myocardial work on MACE occurrence after emergency PCI in patients with acute myocardial infarction[J]. J Clin Cardiol, 2022, 38(12): 960-966. doi: 10.13201/j.issn.1001-1439.2022.12.007

左室心肌做功对急性心肌梗死患者急诊PCI术后MACE发生的预测价值

  • 基金项目:
    苏州市科技计划项目(No:SYSD2018004);张家港科技计划项目(No:ZKS2024、ZKS1821)
详细信息

Predictive value of left ventricular global myocardial work on MACE occurrence after emergency PCI in patients with acute myocardial infarction

More Information
  • 目的 应用左室心肌做功(LVGMW)预测急诊经皮冠状动脉介入术(PCI)后的急性心肌梗死(AMI)患者主要不良心脏事件(MACE)的价值。方法 连续选取2019年1月—2020年12月因AMI行急诊PCI的患者73例,男62例,女11例,平均年龄(59.8±11.8)岁,分别在术后48 h内及术后6个月行常规心脏超声、斑点追踪超声(STE)以及LVGMW检查,检测左室射血分数(LVEF)、左室纵向应变(LVGLS)和LVGMW等;平均随访时间9个月,随访期间观察患者是否发生心力衰竭、恶性心律失常、心绞痛、心肌梗死、死亡等MACE,分析LVGMW对MACE的预测价值。结果 随访期间30例患者发生MACE,其中心力衰竭18例、心绞痛12例。MACE组48 h内的左室整体做功效率(LVGWE)明显低于无MACE组[(83.8±11.4)% vs.(91.4±7.3)%,P=0.002];多因素logistic回归分析结果显示,48 h内LVGWE预测AMI患者急诊PCI术后发生MACE的ROC曲线下面积为0.736(95%CI:0.620~0.852,截点为93.5%,敏感度为80.0%,特异度为59.5%,P=0.001)。结论 48 h内的LVGWE是AMI患者急诊PCI术MACE发生的独立预测因子。
  • 加载中
  • 图 1  两组GLS、GWI、GCW、GWE以及两组差值的比较

    Figure 1.  Comparison of GLS, GWI, GCW, GWE and ΔGLS, ΔGWI, ΔGCW, ΔGWE in two groups

    图 2  无MACE组与MACE组术后48 h的心肌做功牛眼图

    Figure 2.  The bull's-eye of myocardial work index in 48 hours after PCI in the non-MACE group and the MACE group

    图 3  48 h LVGWE的ROC曲线

    Figure 3.  ROC curve of LVGWE in 48 hours predicting MACE

    表 1  两组患者基础资料及治疗情况

    Table 1.  Comparison of clinical and interventional treatment datas X±S, M(P25, P75)

    指标 无MACE组(43例) MACE组(30例) t/χ2/U P
    年龄/岁 57.7±11.4 62.9±11.9 -1.897 0.062
    男性/例(%) 36(83.7) 26(86.7) 0.000 0.989
    高血压/例(%) 19(44.2) 16(53.3) 1.007 0.218
    糖尿病/例(%) 9(20.9) 5(16.7) 0.207 0.654
    吸烟/例(%) 27(62.8) 17(56.7) 0.277 0.544
    GRACE评分 134.5±25.7 139.9±30.6 -0.806 0.423
    心率/(次·min-1) 69.2±14.1 68.5±10.2 -0.843 0.402
    甘油三酯/(mmol·L-1) 2.1±1.5 1.6±1.0 1.839 0.070
    胆固醇/(mmol·L-1) 5.3±5.7 4.6±1.3 -0.744 0.545
    LDL/(mmol·L-1) 2.7±1.0 3.0±1.2 -1.246 0.217
    LP-a/(g·L-1) 1.0±0.2 1.0±0.2 -0.026 0.980
    GLU/(mmol·L-1) 6.6±2.8 6.7±2.5 -0.126 0.900
    肌酐/(μmol·L-1) 73.0±11.6 79.1±22.5 -1.360 0.182
    HbA1c/% 7.4±4.6 6.4±1.5 1.044 0.301
    肌钙蛋白T/(pg·mL-1) 2124.5(590.6,6045.0) 4175.5(1175.0,9620.5) -1.712 0.087
    CKMB/(U·L-1) 100.6±89.4 165.0±194.4 -1.685 0.100
    NT-proBNP/(pg·mL-1) 378.3(148.7,812.0) 623.2(208.13,2753.5) -1.547 0.122
    犯罪血管LAD/例(%) 20(46.5) 19(63.3) 1.288 0.256
    犯罪血管LCX/例(%) 10(23.3) 3(10.0) 2.121 0.145
    犯罪血管RCA/例(%) 13(30.2) 8(26.7) 0.110 0.741
    BMI/(kg·m-2) 25.0±3.0 26.0±9.6 1.955 0.055
    阿司匹林/例(%) 43(100.0) 30(100.0)
    P2Y12拮抗剂/例(%) 43(100.0) 30(100.0)
    他汀/例(%) 43(100.0) 30(100.0)
    美托洛尔/例(%) 35(81.4) 24(80.0) 0.022 0.882
    ACEI/ARB/例(%) 32(74.4) 19(63.3) 0.628 0.428
    注:LDL:低密度脂蛋白;LP-a:脱脂转化酶a;GLU:葡萄糖;HbA1c:糖化血红蛋白;CKMB:肌酸激酶同工酶;NT-proBNP:N末端脑利钠肽前体。
    下载: 导出CSV

    表 2  两组患者术后48 h及6个月的基础心脏超声比较

    Table 2.  Comparison of conventional echocardiographic parameters in 48 hours and 6 months after PCI  X±S

    项目 无MACE组(43例) MACE组(30例) t P
    48 h 6个月 48 h 6个月 48 h 6个月 48 h 6个月
    左房内径/mm 35.9±6.9 36.4±3.7 37.4±3.4 37.1±3.7 -1.157 -0.826 0.251 0.412
    室间隔厚度/mm 10.0±1.3 9.6±1.0 10.1±1.8 9.8±1.4 -0.403 -0.539 0.688 0.591
    LVEDD/mm 49.8±4.3 49.6±4.3 51.0±5.9 49.6±5.5 -0.986 -0.051 0.327 0.960
    左室后壁厚度/mm 9.7±1.0 9.5±0.7 9.6±1.2 9.6±1.0 0.130 -0.436 0.897 0.664
    LVESD/mm 34.9±5.2 33.3±4.4 38.2±6.4 34.0±5.8 -2.340 -0.488 0.022 0.628
    LVEF/% 54.6±7.9 61.1±6.1 50.4±8.2 59.3±7.6 2.121 1.053 0.038 0.296
    肺动脉压/mmHg 25.3±5.1 24.5±4.1 29.0±6.2 25.9±6.6 -2.691 -1.095 0.009 0.277
    E/A 1.1±0.4 1.0±0.2 1.0±0.7 0.9±0.5 0.812 0.188 0.420 0.852
    下腔/mm 14.3±4.0 10.3±3.7 15.5±4.8 11.6±4.1 -1.117 -1.285 0.268 0.203
    下载: 导出CSV

    表 3  两组患者术后48 h、6个月的GLS及做功的比较

    Table 3.  Comparison of LVGLS and LVGMW in 48 hours and 6 months after PCI  X±S

    项目 无MACE组(43例) MACE组(30例) t P
    48 h 6个月 48 h 6个月 48 h 6个月 48 h 6个月
    LVGLS/% 17.4±4.9 20.3±4.5 13.7±5.1 17.7±4.6 -3.106 -2.351 0.003 0.021
    LVGWI/mmHg% 1716.5±606.1 2049.8±460.2 1258.5±491.1 1797.6±556.4 3.426 2.113 0.001 0.038
    LVGCW/mmHg% 1931.9±675.6 2279.2±508.7 675.6±103.0 1981.2±619.5 3.550 2.250 0.001 0.028
    LVGWW/mmHg% 126.5±163.5 69.02±53.8 163.5±24.9 90.8±63.3 -0.805 -1.582 0.424 0.118
    LVGWE/% 91.4±7.3 95.6±3.6 83.8±11.4 93.0±4.6 3.218 2.269 0.002 0.026
    下载: 导出CSV

    表 4  两组患者48 h内的LVGW、GLS与随访6个月的LVGW、GLS差值比较

    Table 4.  Comparison of ΔLVGLS and ΔLVGMW in 48 hours and 6 months after PCI  X±S

    项目 无MACE组(43例) MACE组(30例) t P
    ΔLVGLS/% 2.86±0.64 4.00±0.79 -1.120 0.267
    ΔLVGWI/mmHg% -333.33±71.31 -539.07±80.91 1.889 0.063
    ΔLVGCW/mmHg% -347.21±77.97 -575.57±92.96 1.881 0.064
    ΔLVGWW/mmHg% 57.44±25.39 63.17±18.58 -0.168 0.867
    ΔLVGWE/% -4.05±0.90 -9.60±1.97 2.560 0.014
    注:ΔLVGLS:48 h内与6个月LVGLS的差值;ΔLVGWI:48 h内与6个月LVGWI的差值;ΔLVGCW:48 h内与6个月LVGCW的差值;ΔLVGWW:48 h内与6个月LVGWW的差值;ΔLVGWE:48 h内与6个月LVGWE的差值。
    下载: 导出CSV

    表 5  影响急诊PCI术后AMI患者MACE发生单因素和多因素logistic回归分析

    Table 5.  Univariate and multivariate logistic regression analyses of MACE

    变量 单因素回归分析 多因素回归分析
    B OR 95%CI P B OR 95%CI P
    48 h LVGLS 0.148 1.159 1.046~1.285 0.005 - - - -
    48 h LVGWI -0.002 0.998 0.997~0.999 0.003 - - - -
    48 h LVGCW -0.001 0.999 0.998~0.999 0.002 - - - -
    48 h LVGWE -0.087 0.917 0.865~0.971 0.003 -0.08 0.923 0.872~0.978 0.006
    6个月LVGLS 0.126 1.134 1.015~1.267 0.027 - - - -
    6个月LVGWI -0.001 0.999 0.998~1.000 0.043 - - - -
    6个月LVGCW -0.001 0.999 0.998~1.000 0.032 - - - -
    6个月LVGWE -0.132 0.876 0.774~0.991 0.035 - - - -
    ΔLVGWE -8.198 2.75×10-4 4.44×10-7~0.170 0.012 - - - -
    LVESD 0.112 1.119 1.008~1.242 0.035 - - - -
    LVEF -0.065 0.937 0.879~0.998 0.044 - - - -
    肺动脉压 0.12 1.127 1.024~1.241 0.014 - - - -
    下载: 导出CSV
  • [1]

    Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015[J]. J Am Coll Cardiol, 2017, 70(1): 1-25. doi: 10.1016/j.jacc.2017.04.052

    [2]

    Chew DS, Heikki H, Schmidt G, et al. Change in Left Ventricular Ejection Fraction Following First Myocardial Infarction and Outcome[J]. JACC Clin Electrophysiol, 2018, 4(5): 672-682. doi: 10.1016/j.jacep.2017.12.015

    [3]

    Pedersen F, Butrymovich V, Kelbæk H, et al. Short-and long-term cause of death in patients treated with primary PCI for STEMI[J]. J Am Coll Cardiol, 2014, 64(20): 2101-2108. doi: 10.1016/j.jacc.2014.08.037

    [4]

    张梦玮, 王宇, 段洋, 等. TyG指数及TyG指数联合Grace评分对急性心肌梗死患者预后的预测价值[J]. 临床心血管病杂志, 2021, 37(2): 113-117. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202102005.htm

    [5]

    赵跃华, 王占启, 庞艳彬, 等. 入院时血小板计数与淋巴细胞比值与AMI患者住院期间主要不良心血管事件的相关性[J]. 临床心血管病杂志, 2020, 36(1): 44-50. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202001010.htm

    [6]

    Dokainish H, Rajaram M, Prabhakaran D, et al. Incremental value of left ventricular systolic and diastolic function to determine outcome in patients with acute ST-segment elevation myocardial infarction: the echocardiographic substudy of the OASIS-6 trial[J]. Echocardiography, 2014, 31(5): 569-578. doi: 10.1111/echo.12452

    [7]

    Exner DV, Kavanagh KM, Slawnych MP, et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study[J]. J Am Coll Cardiol, 2007, 50(24): 2275-2284. doi: 10.1016/j.jacc.2007.08.042

    [8]

    Parodi G, Memisha G, Carrabba N, et al. Prevalence, predictors, time course, and long-term clinical implications of left ventricular functional recovery after mechanical reperfusion for acute myocardial infarction[J]. Am J Cardiol, 2007, 100(12): 1718-1722. doi: 10.1016/j.amjcard.2007.07.022

    [9]

    Oh PC, Choi IS, Ahn T, et al. Predictors of recovery of left ventricular systolic dysfunction after acute myocardial infarction: from the korean acute myocardial infarction registry and korean myocardial infarction registry[J]. Korean Circ J, 2013, 43(8): 527-533. doi: 10.4070/kcj.2013.43.8.527

    [10]

    Hall TS, Hallén J, Krucoff MW, et al. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction[J]. Am Heart J, 2015, 169(2): 257-265. e1. doi: 10.1016/j.ahj.2014.10.015

    [11]

    Dagres N, Hindricks G. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?[J]. Eur Heart J, 2013, 34(26): 1964-1971. doi: 10.1093/eurheartj/eht109

    [12]

    Park JJ, Park JB, Park JH, et al. Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure[J]. J Am Coll Cardiol, 2018, 71(18): 1947-1957. doi: 10.1016/j.jacc.2018.02.064

    [13]

    Cha MJ, Kim HS, Kim SH, et al. Prognostic power of global 2D strain according to left ventricular ejection fraction in patients with ST elevation myocardial infarction[J]. PLoS One, 2017, 12(3): e0174160. doi: 10.1371/journal.pone.0174160

    [14]

    Karlsen S, Dahlslett T, Grenne B, et al. Global longitudinal strain is a more reproducible measure of left ventricular function than ejection fraction regardless of echocardiographic training[J]. Cardiovasc Ultrasound, 2019, 17(1): 18. doi: 10.1186/s12947-019-0168-9

    [15]

    Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. Eur Heart J Cardiovasc Imaging, 2015, 16(3): 233-270. doi: 10.1093/ehjci/jev014

    [16]

    Boe E, Skulstad H, Smiseth OA. Myocardial work by echocardiography: a novel method ready for clinical testing[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(1): 18-20. doi: 10.1093/ehjci/jey156

    [17]

    Russell K, Eriksen M, Aaberge L, et al. A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work[J]. Eur Heart J, 2012, 33(6): 724-733. doi: 10.1093/eurheartj/ehs016

    [18]

    Manganaro R, Marchetta S, Dulgheru R, et al. Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(5): 582-590. doi: 10.1093/ehjci/jey188

    [19]

    Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2018, 39(2): 119-177. doi: 10.1093/eurheartj/ehx393

    [20]

    Abou R, Leung M, Goedemans L, et al. Effect of Guideline-Based Therapy on Left Ventricular Systolic Function Recovery After ST-Segment Elevation Myocardial Infarction[J]. Am J Cardiol, 2018, 122(10): 1591-1597. doi: 10.1016/j.amjcard.2018.07.035

    [21]

    Przewlocka-Kosmala M, Marwick TH, Mysiak A, et al. Usefulness of myocardial work measurement in the assessment of left ventricular systolic reserve response to spironolactone in heart failure with preserved ejection fraction[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(10): 1138-1146. doi: 10.1093/ehjci/jez027

    [22]

    Edwards N, Scalia GM, Shiino K, et al. Global Myocardial Work Is Superior to Global Longitudinal Strain to Predict Significant Coronary Artery Disease in Patients With Normal Left Ventricular Function and Wall Motion[J]. J Am Soc Echocardiogr, 2019, 32(8): 947-957. doi: 10.1016/j.echo.2019.02.014

    [23]

    Wang CL, Chan YH, Wu VC, et al. Incremental prognostic value of global myocardial work over ejection fraction and global longitudinal strain in patients with heart failure and reduced ejection fraction[J]. Eur Heart J Cardiovasc Imaging, 2021, 22(3): 348-356. doi: 10.1093/ehjci/jeaa162

    [24]

    Butcher SC, Lustosa RP, Abou R, et al. Prognostic implications of left ventricular myocardial work index in patients with ST-segment elevation myocardial infarction and reduced left ventricular ejection fraction[J]. Eur Heart J Cardiovasc Imaging, 2022, 23(5): 699-707. doi: 10.1093/ehjci/jeab096

    [25]

    Lustosa RP, Butcher SC, van der Bijl P, et al. Global Left Ventricular Myocardial Work Efficiency and Long-Term Prognosis in Patients After ST-Segment-Elevation Myocardial Infarction[J]. Circ Cardiovasc Imaging, 2021, 14(3): e012072. doi: 10.1161/CIRCIMAGING.120.012072

  • 加载中

(3)

(5)

计量
  • 文章访问数:  1633
  • PDF下载数:  396
  • 施引文献:  0
出版历程
收稿日期:  2022-08-09
刊出日期:  2022-12-13

目录